{"id":315201,"date":"2024-02-24T13:00:48","date_gmt":"2024-02-24T07:30:48","guid":{"rendered":"https:\/\/www.scconline.com\/blog\/?p=315201"},"modified":"2024-02-24T14:29:19","modified_gmt":"2024-02-24T08:59:19","slug":"shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited","status":"publish","type":"post","link":"https:\/\/www.scconline.com\/blog\/post\/2024\/02\/24\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\/","title":{"rendered":"Shardul Amarchand Mangaldas &amp; Co. advises Eris Lifesciences Limited on the acquisition of a majority stake in Swiss Parenterals Limited"},"content":{"rendered":"<div style=\"text-align: justify; line-height: 150%;\">\n<p style=\"margin-bottom: 3%;\">Shardul Amarchand Mangaldas advised Eris Lifesciences Limited (&#8220;<span style=\"font-weight: bold;\">Eris<\/span>&#8221;) on the acquisition of a majority stake in Swiss Parenterals Limited (&#8220;<span style=\"font-weight: bold;\">SPL<\/span>&#8221;) from the existing shareholders of SPL by Eris and certain individual purchasers. The aggregate deal value is approximately INR 875 Crores (USD 105.38 million). The consideration was paid through a combination of cash consideration and issuance by Eris of secured, redeemable non-convertible debentures.<\/p>\n<p style=\"margin-bottom: 3%;\">After completion of the transaction, Eris holds 51% of the share capital of SPL and the individual purchasers, collectively, hold ~19% of the share capital of SPL.<\/p>\n<p style=\"margin-bottom: 3%;\">The transaction augments the capability of Eris in the sterile injectables segment.<\/p>\n<p style=\"margin-bottom: 3%;\">The transaction team was led by Nivedita Tiwari, Partner; Devesh Pandey, Partner; Shailesh Singh, Principal Associate; and Anushka Ganguli, Associate.<\/p>\n<p style=\"margin-bottom: 3%;\">The financing team was led by Shilpa Mankar Ahluwalia, Partner; Shubhangi Garg, Partner; Utsav Dubey, Principal Associate; Purva Anand, Associate; and Gunjan Shrivastav, Associate.<\/p>\n<p style=\"margin-bottom: 3%;\">Tax team was led by Gouri Puri, Partner and Rahul Yadav, Counsel.<\/p>\n<p style=\"margin-bottom: 3%;\">Ritwik Bhattacharya, Partner advised on the competition law aspects.<\/p>\n<p style=\"margin-bottom: 3%;\">SPL and the Sellers were advised by Cyril Amarchand Mangaldas on the legal aspects.<\/p>\n<p style=\"font-weight: bold; text-decoration: underline;\">About Shardul Amarchand Mangaldas &amp; Co:<\/p>\n<p style=\"margin-bottom: 3%;\">Shardul Amarchand Mangaldas &amp; Co., founded on a century of legal achievements, is one of India&#8217;s leading full-service law firms. The Firm&#8217;s mission is to enable business by providing solutions as trusted advisers through excellence, responsiveness, innovation, and collaboration. SAM &amp; Co. is known globally for its exceptional practices in mergers &amp; acquisitions, private equity, competition law, insolvency &amp; bankruptcy, dispute resolution, international commercial arbitration, capital markets, banking &amp; finance, tax, intellectual property, data protection and data privacy, technology law and projects &amp; infrastructure.<\/p>\n<p style=\"margin-bottom: 3%;\">The Firm has a pan-India presence and has been at the helm of major headline transactions and litigations in all sectors, besides advising major multinational corporates on their entry into the Indian market and their business strategy. Currently, the Firm has over 824 lawyers including 165 Partners, offering legal services through its offices in New Delhi, Mumbai, Gurugram, Ahmedabad, Kolkata, Bengaluru, and Chennai.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Shardul Amarchand Mangaldas advised Eris Lifesciences Limited (&#8220;Eris&#8221;) on the acquisition of a majority stake in Swiss Parenterals Limited (&#8220;SPL&#8221;) from the <\/p>\n","protected":false},"author":8808,"featured_media":315247,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[45282,2],"tags":[63298,65707,61012,46701,65706],"class_list":["post-315201","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-law-firms-news","category-news","tag-eris-lifesciences-limited","tag-eris-of-secured","tag-majority-stake","tag-shardul-amarchand-mangaldas","tag-swiss-parenterals-limited"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.4 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Shardul Amarchand Mangaldas &amp; Co. advises Eris Lifesciences Limited on the acquisition of a majority stake in Swiss Parenterals Limited | SCC Times<\/title>\n<meta name=\"description\" content=\"Shardul Amarchand Mangaldas advised Eris Lifesciences Limited (\u201cEris\u201d) on the acquisition of a majority stake in Swiss Parenterals Limited\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.scconline.com\/blog\/post\/2024\/02\/24\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Shardul Amarchand Mangaldas &amp; Co. advises Eris Lifesciences Limited on the acquisition of a majority stake in Swiss Parenterals Limited\" \/>\n<meta property=\"og:description\" content=\"Shardul Amarchand Mangaldas advised Eris Lifesciences Limited (\u201cEris\u201d) on the acquisition of a majority stake in Swiss Parenterals Limited\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.scconline.com\/blog\/post\/2024\/02\/24\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\/\" \/>\n<meta property=\"og:site_name\" content=\"SCC Times\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/scc.online\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-02-24T07:30:48+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-02-24T08:59:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/02\/Eris-Lifesciences-Limited.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"886\" \/>\n\t<meta property=\"og:image:height\" content=\"590\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Bhumika Indulia\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Shardul Amarchand Mangaldas &amp; Co. advises Eris Lifesciences Limited on the acquisition of a majority stake in Swiss Parenterals Limited\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Bhumika Indulia\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2024\\\/02\\\/24\\\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2024\\\/02\\\/24\\\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\\\/\"},\"author\":{\"name\":\"Bhumika Indulia\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/#\\\/schema\\\/person\\\/919ec47cc1b871b362af05740398033a\"},\"headline\":\"Shardul Amarchand Mangaldas &amp; Co. advises Eris Lifesciences Limited on the acquisition of a majority stake in Swiss Parenterals Limited\",\"datePublished\":\"2024-02-24T07:30:48+00:00\",\"dateModified\":\"2024-02-24T08:59:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2024\\\/02\\\/24\\\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\\\/\"},\"wordCount\":350,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2024\\\/02\\\/24\\\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/Eris-Lifesciences-Limited.webp\",\"keywords\":[\"Eris Lifesciences Limited\",\"Eris of secured\",\"Majority Stake\",\"Shardul Amarchand Mangaldas\",\"Swiss Parenterals Limited\"],\"articleSection\":[\"Law Firms News\",\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2024\\\/02\\\/24\\\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2024\\\/02\\\/24\\\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\\\/\",\"url\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2024\\\/02\\\/24\\\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\\\/\",\"name\":\"Shardul Amarchand Mangaldas &amp; Co. advises Eris Lifesciences Limited on the acquisition of a majority stake in Swiss Parenterals Limited | SCC Times\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2024\\\/02\\\/24\\\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2024\\\/02\\\/24\\\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/Eris-Lifesciences-Limited.webp\",\"datePublished\":\"2024-02-24T07:30:48+00:00\",\"dateModified\":\"2024-02-24T08:59:19+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/#\\\/schema\\\/person\\\/919ec47cc1b871b362af05740398033a\"},\"description\":\"Shardul Amarchand Mangaldas advised Eris Lifesciences Limited (\u201cEris\u201d) on the acquisition of a majority stake in Swiss Parenterals Limited\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2024\\\/02\\\/24\\\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2024\\\/02\\\/24\\\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2024\\\/02\\\/24\\\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/Eris-Lifesciences-Limited.webp\",\"contentUrl\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/Eris-Lifesciences-Limited.webp\",\"width\":886,\"height\":590,\"caption\":\"Eris Lifesciences Limited\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2024\\\/02\\\/24\\\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shardul Amarchand Mangaldas &amp; Co. advises Eris Lifesciences Limited on the acquisition of a majority stake in Swiss Parenterals Limited\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/\",\"name\":\"SCC Times\",\"description\":\"Bringing you the Best Analytical Legal News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/#\\\/schema\\\/person\\\/919ec47cc1b871b362af05740398033a\",\"name\":\"Bhumika Indulia\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/84c1b51748d0297cf12e5a898eccb7bd3eb5f0ab4ae8e275e2e65c4c83f84740?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/84c1b51748d0297cf12e5a898eccb7bd3eb5f0ab4ae8e275e2e65c4c83f84740?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/84c1b51748d0297cf12e5a898eccb7bd3eb5f0ab4ae8e275e2e65c4c83f84740?s=96&d=mm&r=g\",\"caption\":\"Bhumika Indulia\"},\"url\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/author\\\/editor_1\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Shardul Amarchand Mangaldas &amp; Co. advises Eris Lifesciences Limited on the acquisition of a majority stake in Swiss Parenterals Limited | SCC Times","description":"Shardul Amarchand Mangaldas advised Eris Lifesciences Limited (\u201cEris\u201d) on the acquisition of a majority stake in Swiss Parenterals Limited","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.scconline.com\/blog\/post\/2024\/02\/24\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\/","og_locale":"en_US","og_type":"article","og_title":"Shardul Amarchand Mangaldas & Co. advises Eris Lifesciences Limited on the acquisition of a majority stake in Swiss Parenterals Limited","og_description":"Shardul Amarchand Mangaldas advised Eris Lifesciences Limited (\u201cEris\u201d) on the acquisition of a majority stake in Swiss Parenterals Limited","og_url":"https:\/\/www.scconline.com\/blog\/post\/2024\/02\/24\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\/","og_site_name":"SCC Times","article_publisher":"https:\/\/www.facebook.com\/scc.online\/","article_published_time":"2024-02-24T07:30:48+00:00","article_modified_time":"2024-02-24T08:59:19+00:00","og_image":[{"width":886,"height":590,"url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/02\/Eris-Lifesciences-Limited.jpg","type":"image\/jpeg"}],"author":"Bhumika Indulia","twitter_card":"summary_large_image","twitter_title":"Shardul Amarchand Mangaldas &amp; Co. advises Eris Lifesciences Limited on the acquisition of a majority stake in Swiss Parenterals Limited","twitter_misc":{"Written by":"Bhumika Indulia","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.scconline.com\/blog\/post\/2024\/02\/24\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\/#article","isPartOf":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2024\/02\/24\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\/"},"author":{"name":"Bhumika Indulia","@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/919ec47cc1b871b362af05740398033a"},"headline":"Shardul Amarchand Mangaldas &amp; Co. advises Eris Lifesciences Limited on the acquisition of a majority stake in Swiss Parenterals Limited","datePublished":"2024-02-24T07:30:48+00:00","dateModified":"2024-02-24T08:59:19+00:00","mainEntityOfPage":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2024\/02\/24\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\/"},"wordCount":350,"commentCount":0,"image":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2024\/02\/24\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\/#primaryimage"},"thumbnailUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/02\/Eris-Lifesciences-Limited.webp","keywords":["Eris Lifesciences Limited","Eris of secured","Majority Stake","Shardul Amarchand Mangaldas","Swiss Parenterals Limited"],"articleSection":["Law Firms News","News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.scconline.com\/blog\/post\/2024\/02\/24\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.scconline.com\/blog\/post\/2024\/02\/24\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\/","url":"https:\/\/www.scconline.com\/blog\/post\/2024\/02\/24\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\/","name":"Shardul Amarchand Mangaldas &amp; Co. advises Eris Lifesciences Limited on the acquisition of a majority stake in Swiss Parenterals Limited | SCC Times","isPartOf":{"@id":"https:\/\/www.scconline.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2024\/02\/24\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\/#primaryimage"},"image":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2024\/02\/24\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\/#primaryimage"},"thumbnailUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/02\/Eris-Lifesciences-Limited.webp","datePublished":"2024-02-24T07:30:48+00:00","dateModified":"2024-02-24T08:59:19+00:00","author":{"@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/919ec47cc1b871b362af05740398033a"},"description":"Shardul Amarchand Mangaldas advised Eris Lifesciences Limited (\u201cEris\u201d) on the acquisition of a majority stake in Swiss Parenterals Limited","breadcrumb":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2024\/02\/24\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.scconline.com\/blog\/post\/2024\/02\/24\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.scconline.com\/blog\/post\/2024\/02\/24\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\/#primaryimage","url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/02\/Eris-Lifesciences-Limited.webp","contentUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/02\/Eris-Lifesciences-Limited.webp","width":886,"height":590,"caption":"Eris Lifesciences Limited"},{"@type":"BreadcrumbList","@id":"https:\/\/www.scconline.com\/blog\/post\/2024\/02\/24\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.scconline.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Shardul Amarchand Mangaldas &amp; Co. advises Eris Lifesciences Limited on the acquisition of a majority stake in Swiss Parenterals Limited"}]},{"@type":"WebSite","@id":"https:\/\/www.scconline.com\/blog\/#website","url":"https:\/\/www.scconline.com\/blog\/","name":"SCC Times","description":"Bringing you the Best Analytical Legal News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.scconline.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/919ec47cc1b871b362af05740398033a","name":"Bhumika Indulia","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/84c1b51748d0297cf12e5a898eccb7bd3eb5f0ab4ae8e275e2e65c4c83f84740?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/84c1b51748d0297cf12e5a898eccb7bd3eb5f0ab4ae8e275e2e65c4c83f84740?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/84c1b51748d0297cf12e5a898eccb7bd3eb5f0ab4ae8e275e2e65c4c83f84740?s=96&d=mm&r=g","caption":"Bhumika Indulia"},"url":"https:\/\/www.scconline.com\/blog\/post\/author\/editor_1\/"}]}},"jetpack_featured_media_url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/02\/Eris-Lifesciences-Limited.webp","jetpack_sharing_enabled":true,"jetpack-related-posts":[],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/315201","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/users\/8808"}],"replies":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/comments?post=315201"}],"version-history":[{"count":0,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/315201\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/media\/315247"}],"wp:attachment":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/media?parent=315201"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/categories?post=315201"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/tags?post=315201"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}